Follow The Filings

TWST position history

The shares of Twist Bioscience (TWST) that ARK Investment Management LLC reported in each quarter’s 13F.

Equity, COMMON STOCK

Shares held by quarter

New Add Reduce Exit

  1. 2021 Q3: 3,946,409 shares, $422M, 1.0% of portfolio
  2. 2021 Q4: 3,767,203 shares, $292M, 0.88% of portfolio, Reduce −4.5%
  3. 2022 Q1: 5,264,255 shares, $260M, 1.1% of portfolio, Add +39.7%
  4. 2022 Q2: 6,267,721 shares, $213M, 1.3% of portfolio, Add +19.1%
  5. 2022 Q3: 6,676,908 shares, $235M, 1.6% of portfolio, Add +6.5%
  6. 2022 Q4: 6,700,855 shares, $160M, 1.4% of portfolio, Add +0.4%
  7. 2023 Q1: 7,179,112 shares, $108M, 0.74% of portfolio, Add +7.1%
  8. 2023 Q2: 6,959,240 shares, $142M, 0.94% of portfolio, Reduce −3.1%
  9. 2023 Q3: 6,785,983 shares, $137M, 1.1% of portfolio, Reduce −2.5%
  10. 2023 Q4: 7,213,257 shares, $266M, 1.6% of portfolio, Add +6.3%
  11. 2024 Q1: 6,943,975 shares, $238M, 1.6% of portfolio, Reduce −3.7%
  12. 2024 Q2: 6,129,375 shares, $302M, 2.7% of portfolio, Reduce −11.7%
  13. 2024 Q3: 5,358,093 shares, $242M, 2.2% of portfolio, Reduce −12.6%
  14. 2024 Q4: 5,595,865 shares, $260M, 2.2% of portfolio, Add +4.4%
  15. 2025 Q1: 6,241,595 shares, $245M, 2.5% of portfolio, Add +11.5%
  16. 2025 Q2: 6,400,441 shares, $235M, 1.7% of portfolio, Add +2.5%
  17. 2025 Q3: 6,726,808 shares, $189M, 1.1% of portfolio, Add +5.1%
  18. 2025 Q4: 7,559,495 shares, $240M, 1.6% of portfolio, Add +12.4%
  19. 2026 Q1: 6,342,733 shares, $301M, 2.3% of portfolio, Reduce −16.1%
  20. 2026 Q2: 4,549,803 shares, $468M, 3.0% of portfolio, Reduce −28.3%
  21. 2026 Q3: 3,398,057 shares, $657M, 3.8% of portfolio, Reduce −25.3%
Holdings date Value % of holdings Shares Filing date All 13F holders